Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgery Partners CS (NQ: SGRY )

28.75 -0.05 (-0.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners CS

< Previous 1 2 3 4 Next >
9 Analysts Assess Surgery Partners: What You Need To Know
Via Benzinga
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat
Uncovering Noteworthy Technical Analysis Findings for SURGERY PARTNERS INC (NASDAQ:SGRY).
Promising Signs: SURGERY PARTNERS INC Setting the Stage for a Breakout. 
Via Chartmill
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Concentra, a subsidiary of select medical, recently priced its IPO at $23.50 per share. Concentra offers occupational health services with 547 centers in 41 states. 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What 8 Analyst Ratings Have To Say About Surgery Partners
Via Benzinga
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Via Benzinga
Expert Ratings For Surgery Partners
Via Benzinga
Preview: Surgery Partners's Earnings
Via Benzinga
The Latest Analyst Ratings for Surgery Partners
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q2 2024
SGRY stock results show that Surgery Partners beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%). 
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q1 2024
SGRY stock results show that Surgery Partners beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Expert Ratings for Surgery Partners
Via Benzinga
A Preview Of Surgery Partners's Earnings
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
Analyst Expectations for Surgery Partners's Future
Via Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (NASDAQ: SGRY). "That industry has been up and down and up and down," he added. 
Via Benzinga
Surgery Partners feeling no pinch from macroeconomic weakness
Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. 
Via MarketBeat
Exposures COVID-19
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
From Teladoc Health, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
Surgery Partners Stock Getting Closer To Key Technical Benchmark
The Relative Strength Rating for Surgery Partners stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 74. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.